ArticleTechnology and health care : official journal of the European Society for Engineering and Medicine2025
NAmiRNA-31 regulates cell cycle by activating ZWINT and promotes lung adenocarcinoma tumor development.
Article in Technology and health care : official journal of the European Society for Engineering and Medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It carries an expression of concern. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
- Expression of concern
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
ObjectiveThis study aimed to identify Nuclear-activated miRNA (NAmiRNA) and their target genes linked to the prognosis of Lung adenocarcinoma tumor (LUAD), and provide novel diagnostic and therapeutic targets for this devastating disease.MethodsPutative target (Messenger RNA)mRNA of the prognostic (MicroRNA)miRNA was obtained by interesting the differentially expressed mRNAs with predicted targets from targetscan database. Functional validation experiments were conducted utilizing LUAD cell lines to corroborate the interactions between the identified miRNA and their target mRNAs. Collect cancer and adjacent tissues from patients to detect the expression of target genes. The effects of miRNA-target gene interactions on LUAD cell growth were investigated by (Cell Counting Kit-8)CCK8, colony formation assay and flow cytometry.ResultsOur findings revealed that both miR-31 and its target gene, ZWINT, were considerably overexpressed in LUAD individuals. The results of qPCR and WB indicated that miR-31 effectively upregulated the expression of (Zeste White 10 interactor)ZWINT. The transfection with miR-31mimic enhanced the activity of LUAD cells and promoted colony growth. Knockdown of ZWINT expression resulted in (G2 to mitosis)G2/M phase cell arrest, concurrent with a decrease in Cyclin B1 and (Cyclin-Dependent Kinase 1)CDK1 proteins.Conclusion(nuclear activating mirna-31)NAmiRNA-31 and ZWINT are upregulated in LUAD, suggest their potential as biomarkers for the unfavorable prognosis.
Indexed as
Identifiers
40421481What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.